19 May 2026Policy & Regulation
ZYN becomes Trump World's nicotine of choice
Nicotine pouches have become fashionable across Trump's political orbit, including Health Secretary RFK Jr., as Philip Morris International's ZYN brand captures 76 percent of the US market. The FDA authorized 20 ZYN products in January as 'appropriate for public health protection' compared to cigarettes, while the brand reached 334 million unit shipments from just 1 million six years ago. PMI's CEO now frames nicotine as 'misunderstood' with 'cognitive benefits,' finding clear political receptivity within Trump's health leadership despite public health concerns about youth uptake and addiction in non-smokers. The cultural adoption in elite political circles accelerates market growth and regulatory acceptance for PMI's smoke-free transition strategy, with ZYN generating roughly six times more profit per unit than international cigarette sales.
From Putin signs gas deal as Xi hints at regret